tiprankstipranks
Trending News
More News >
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
US Market

Sonnet BioTherapeutics Holdings (SONN) Income Statement

Compare
629 Followers

Sonnet BioTherapeutics Holdings Income Statement

Last quarter (Q3 2025), Sonnet BioTherapeutics Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Sonnet BioTherapeutics Holdings's net income was $-3.78M. See Sonnet BioTherapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 18.63K$ 147.81K$ 349.94K$ 483.63K$ 0.00
Gross Profit
$ 18.63K$ 147.81K$ -21.09M$ 483.63K$ -58.31K
Operating Expenses
$ 11.87M$ 18.94M$ 8.58M$ 25.57M$ 17.41M
Depreciation and Amortization
$ 83.11K$ 75.75K$ 93.26K$ 95.16K$ 58.31K
EBITDA
$ -11.77M$ -18.72M$ -29.58M$ -24.99M$ -24.24M
Operating Income
$ -11.85M$ -18.79M$ -29.67M$ -25.09M$ -17.41M
Other Income/Expenses
$ 4.41M$ -40.08K$ -52.48K$ 103.47K$ -6.85M
Pretax Income
$ -7.44M$ -18.83M$ -29.72M$ -24.98M$ -24.27M
Net Income
$ -7.44M$ -18.83M$ -29.77M$ -25.01M$ -24.27M
Per Share Metrics
Basic EPS
$ -11.35$ -145.12$ -1.20K$ -2.51K$ -17.16K
Diluted EPS
$ -11.35$ -145.12$ -1.20K$ -2.51K$ -17.16K
Weighted Average Shares Outstanding
655.24K 129.77K 24.70K 9.96K 3.82K
Weighted Average Shares Outstanding (Diluted)
655.24K 129.77K 24.70K 9.96K 3.82K
Currency in USD

Sonnet BioTherapeutics Holdings Earnings and Revenue History